Evoke Pharma, Inc. (EVOK) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.42M |
| Enterprise Value | -15,690 |
| P/E Ratio | -10.28 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 2.36 |
| Price/Book Ratio | 8.37 |
| Enterprise/Revenue | 1.55 |
| Enterprise/EBITDA | -5.04 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -0.34 |
| Operating Margin | -0.34 |
AD
Management Effectiveness
| Return On Assets | -0.17 |
| Return On Equity | -0.7 |
Income Statement
| Revenue | 10.25M |
| Revenue/Share | 3.14 |
| Gross Profit | 9.89M |
| EBITDA | 353,313 |
| Net Income | -5.35M |
| Diluted EPS | -2.81 |
Balance Sheet
| Total Cash | 11.58M |
| Total Cash/Share | 4.53 |
| Total Debt | 5.11M |
| Total Debt/Equity | 1.52 |
| Current Ratio | 1.27 |
| Book Value Per Share | 1.31 |
Price History
| 52-Week Change | 146.64 |
| 52-Week High | 11 |
| 52-Week Low | 1.94 |
| Moving Average 50 Days | 8.52 |
| Moving Average 200 Days | 5.04 |
Statistics
| Average Volume | 100,366 |
| Shares Outstanding | 1.72M |
| % Held by Institutions | 6.09 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | August 01, 2024 |
AD
